62 related articles for article (PubMed ID: 33309051)
1. Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.
Nahshon C; Segev Y; Gemer O; Bar Noy T; Schmidt M; Ostrovsky L; Lavie O
Gynecol Oncol; 2021 Mar; 160(3):755-762. PubMed ID: 33309051
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of BRAT1-related disease: a systematic literature review.
Kong W; Cao X; Lu C
Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38607605
[TBL] [Abstract][Full Text] [Related]
3. Germline
Evans DG; Woodward ER; Bajalica-Lagercrantz S; Oliveira C; Frebourg T
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327514
[TBL] [Abstract][Full Text] [Related]
4. The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies.
Hickey I; Jha S; Wyld L
Gynecol Oncol; 2021 Mar; 160(3):763-770. PubMed ID: 33317909
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
6. A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women.
Loving VA; Luiten RC; Siettmann JM; Mina LA
Acad Radiol; 2022 Jan; 29 Suppl 1():S239-S245. PubMed ID: 33339730
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
[TBL] [Abstract][Full Text] [Related]
9. Population-based Screening for Hereditary Colorectal Cancer Variants in Japan.
Fujita M; Liu X; Iwasaki Y; Terao C; Mizukami K; Kawakami E; Takata S; Inai C; Aoi T; Mizukoshi M; Maejima K; Hirata M; Murakami Y; Kamatani Y; Kubo M; Akagi K; Matsuda K; Nakagawa H; Momozawa Y
Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2132-2141.e9. PubMed ID: 33309985
[TBL] [Abstract][Full Text] [Related]
10. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
de Jonge MM; de Kroon CD; Jenner DJ; Oosting J; de Hullu JA; Mourits MJE; Gómez Garcia EB; Ausems MGEM; Margriet Collée J; van Engelen K; van de Beek I; ; Smit VTHBM; Rookus MA; de Bock GH; van Leeuwen FE; Bosse T; Dekkers OM; van Asperen CJ
J Natl Cancer Inst; 2021 Sep; 113(9):1203-1211. PubMed ID: 33710348
[TBL] [Abstract][Full Text] [Related]
11. Downstream Revenue Generated by a Cancer Genetic Counselor.
Mauer CB; Reys BD; Hall RE; Campbell CL; Pirzadeh-Miller SM
JCO Oncol Pract; 2021 Sep; 17(9):e1394-e1402. PubMed ID: 33555913
[TBL] [Abstract][Full Text] [Related]
12. Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (
Hall MJ; Bernhisel R; Hughes E; Larson K; Rosenthal ET; Singh NA; Lancaster JM; Kurian AW
Cancer Prev Res (Phila); 2021 Apr; 14(4):433-440. PubMed ID: 33509806
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
; Dorling L; Carvalho S; Allen J; González-Neira A; Luccarini C; Wahlström C; Pooley KA; Parsons MT; Fortuno C; Wang Q; Bolla MK; Dennis J; Keeman R; Alonso MR; Álvarez N; Herraez B; Fernandez V; Núñez-Torres R; Osorio A; Valcich J; Li M; Törngren T; Harrington PA; Baynes C; Conroy DM; Decker B; Fachal L; Mavaddat N; Ahearn T; Aittomäki K; Antonenkova NN; Arnold N; Arveux P; Ausems MGEM; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Białkowska K; Blomqvist C; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Briceno I; Brüning T; Burwinkel B; Cameron DA; Camp NJ; Campbell A; Carracedo A; Castelao JE; Cessna MH; Chanock SJ; Christiansen H; Collée JM; Cordina-Duverger E; Cornelissen S; Czene K; Dörk T; Ekici AB; Engel C; Eriksson M; Fasching PA; Figueroa J; Flyger H; Försti A; Gabrielson M; Gago-Dominguez M; Georgoulias V; Gil F; Giles GG; Glendon G; Garcia EBG; Alnæs GIG; Guénel P; Hadjisavvas A; Haeberle L; Hahnen E; Hall P; Hamann U; Harkness EF; Hartikainen JM; Hartman M; He W; Heemskerk-Gerritsen BAM; Hillemanns P; Hogervorst FBL; Hollestelle A; Ho WK; Hooning MJ; Howell A; Humphreys K; Idris F; Jakubowska A; Jung A; Kapoor PM; Kerin MJ; Khusnutdinova E; Kim SW; Ko YD; Kosma VM; Kristensen VN; Kyriacou K; Lakeman IMM; Lee JW; Lee MH; Li J; Lindblom A; Lo WY; Loizidou MA; Lophatananon A; Lubiński J; MacInnis RJ; Madsen MJ; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Maurer T; Mavroudis D; McLean C; Meindl A; Mensenkamp AR; Michailidou K; Miller N; Mohd Taib NA; Muir K; Mulligan AM; Nevanlinna H; Newman WG; Nordestgaard BG; Ng PS; Oosterwijk JC; Park SK; Park-Simon TW; Perez JIA; Peterlongo P; Porteous DJ; Prajzendanc K; Prokofyeva D; Radice P; Rashid MU; Rhenius V; Rookus MA; Rüdiger T; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Schürmann P; Shah M; Sohn C; Southey MC; Surowy H; Suvanto M; Thanasitthichai S; Tomlinson I; Torres D; Truong T; Tzardi M; Valova Y; van Asperen CJ; Van Dam RM; van den Ouweland AMW; van der Kolk LE; van Veen EM; Wendt C; Williams JA; Yang XR; Yoon SY; Zamora MP; Evans DG; de la Hoya M; Simard J; Antoniou AC; Borg Å; Andrulis IL; Chang-Claude J; García-Closas M; Chenevix-Trench G; Milne RL; Pharoah PDP; Schmidt MK; Spurdle AB; Vreeswijk MPG; Benitez J; Dunning AM; Kvist A; Teo SH; Devilee P; Easton DF
N Engl J Med; 2021 Feb; 384(5):428-439. PubMed ID: 33471991
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.
Pujol P; Barberis M; Beer P; Friedman E; Piulats JM; Capoluongo ED; Garcia Foncillas J; Ray-Coquard I; Penault-Llorca F; Foulkes WD; Turnbull C; Hanson H; Narod S; Arun BK; Aapro MS; Mandel JL; Normanno N; Lambrechts D; Vergote I; Anahory M; Baertschi B; Baudry K; Bignon YJ; Bollet M; Corsini C; Cussenot O; De la Motte Rouge T; Duboys de Labarre M; Duchamp F; Duriez C; Fizazi K; Galibert V; Gladieff L; Gligorov J; Hammel P; Imbert-Bouteille M; Jacot W; Kogut-Kubiak T; Lamy PJ; Nambot S; Neuzillet Y; Olschwang S; Rebillard X; Rey JM; Rideau C; Spano JP; Thomas F; Treilleux I; Vandromme M; Vendrell J; Vintraud M; Zarca D; Hughes KS; Alés Martínez JE
Eur J Cancer; 2021 Mar; 146():30-47. PubMed ID: 33578357
[TBL] [Abstract][Full Text] [Related]
15. Surgical decision making in premenopausal
Gaba F; Goyal S; Marks D; Chandrasekaran D; Evans O; Robbani S; Tyson C; Legood R; Saridogan E; McCluggage WG; Hanson H; Singh N; Evans DG; Menon U; Manchanda R;
J Med Genet; 2022 Feb; 59(2):122-132. PubMed ID: 33568437
[TBL] [Abstract][Full Text] [Related]
16. The Perspectives of Fertility Preservation in Women with Endometrial Cancer.
Knez J; Al Mahdawi L; Takač I; Sobočan M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546293
[TBL] [Abstract][Full Text] [Related]
17. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
Siedel JH; Ring KL; Hu W; Dood RL; Wang Y; Baggerly K; Darcy KM; Conrads TP; Gallagher S; Tshiaba P; Neff C; Timms KM; Mangala S; Westin SN; Broaddus R; Lopez-Berestein G; Lu KH; Coleman RL; Maxwell GL; Sood AK
Gynecol Oncol; 2021 Mar; 160(3):777-785. PubMed ID: 33563487
[TBL] [Abstract][Full Text] [Related]
19. Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in Japan.
Ueki A; Yoshida R; Kosaka T; Matsubayashi H
J Hum Genet; 2023 Aug; 68(8):517-526. PubMed ID: 37088789
[TBL] [Abstract][Full Text] [Related]
20. Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review.
Bertozzi S; Londero AP; Xholli A; Azioni G; Di Vora R; Paudice M; Bucimazza I; Cedolini C; Cagnacci A
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
